| abstract |
The invention relates to the use of fungal lanostanes of the general formulas I and II as inhibitors of 3alpha-hydroxysteroid dehydrogenase and cyclooxygenases-I and -II, which are known as key enzymes in the inflammation cascade. Furthermore, the invention relates to the use of fungal lanostanes of the general formulas I and II as individual substances or mixtures of individual substances as a component of medicaments and preparations for the treatment of disease states, the formation and pathogenesis of the 3alpha-hydroxysteroid dehydrogenase and the cyclooxygenase I and - II are involved, as well as cosmetics and health care products. |